Directory

>

Tony Koutsoukos

Tony Koutsoukos

Research Fellow | Ultragenyx

California, Novato, United States

View contact details (it's free)

Tony Koutsoukos

Summary

Tony Koutsoukos is a seasoned executive leader in the field of Biostatistics and Data Management, boasting over 20 years of experience in clinical trials. He has played a pivotal role in the approval of FOLOTYN, a groundbreaking anti-cancer therapy for patients with Peripheral T-cell lymphoma. With extensive regulatory filing experience with both the FDA and EMA, he has a strong focus on oncology. Tony has successfully managed departmental budgets and has implemented new Standard Operating Procedures (SOPs) in Statistics, Programming, and Data Management. His leadership style emphasizes mentorship and staff development, fostering strong relationships within the Biometrics department and across clinical development teams. With a history of working in various high-profile organizations, he brings a wealth of knowledge and expertise to his current role at Ultragenyx Pharmaceutical.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Industry-specific interests

Emerging Technologies

Leadership Development

Organisational experience

Corporate Experience

Tony Koutsoukos

Work Experience

company logo

VP Biometrics at

Ultragenyx

October 2013 - Present

Logos provided by Logo.dev

Frequently Asked Questions about Tony Koutsoukos

What is Tony Koutsoukos email address?

Tony Koutsoukos's primary email address is ****@allos.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Tony Koutsoukos work for?

Tony Koutsoukos is a Research Fellow at Ultragenyx.

How can I directly contact Tony Koutsoukos?

To contact Tony Koutsoukos directly, you can use the email address ****@allos.com. Complete contact information is available upon registration with Muraena.

Who is Tony Koutsoukos?

Tony Koutsoukos is a seasoned executive leader in the field of Biostatistics and Data Management, boasting over 20 years of experience in clinical trials. He has played a pivotal role in the approval of FOLOTYN, a groundbreaking anti-cancer therapy for patients with Peripheral T-cell lymphoma. With extensive regulatory filing experience with both the FDA and EMA, he has a strong focus on oncology. Tony has successfully managed departmental budgets and has implemented new Standard Operating Procedures (SOPs) in Statistics, Programming, and Data Management. His leadership style emphasizes mentorship and staff development, fostering strong relationships within the Biometrics department and across clinical development teams. With a history of working in various high-profile organizations, he brings a wealth of knowledge and expertise to his current role at Ultragenyx Pharmaceutical.

Tony`s contact details

mail

****@allos.com

***********@ultragenyx.com

Colleagues

avatar
Heather Lau

Pediatric Resident

avatar
Gil Stevens

Sr. Engineer

avatar
Erik Harris

Lieutenant Commander

avatar
Hilary Beggs

Assistant Professor

avatar
Deborah Dunsire

Executive Director

avatar
Stanley Krolczyk

Global senior Medical Director

avatar
Julia Paarlberg

Engineering Co-op

avatar
Matthias Mueller

Technical Services Scientist

avatar
Wendy Putnam

Scientist

avatar
Janaiah Kota

Postdoctoral Fellow | Researcher | Gene Therapy Scientist

View Contact details (it's free)
Request Profile Removal